# Damora Therapeutics (DMRA) — Analyst Forecast

DMRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/dmra/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 29, 2026 | Wedbush | Maintained | Outperform | $40.00 |
| Sep 25, 2026 | Guggenheim | Maintained | Buy | $60.00 |
| Jul 30, 2026 | Wedbush | Maintained | Outperform | $40.00 |
| Jul 27, 2026 | Jefferies | Initiated Coverage | Buy | $50.00 |
| Jul 21, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Jun 12, 2026 | Wedbush | Maintained | Outperform | $35.00 |
| Jun 11, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $45.00 |
| May 28, 2026 | Wedbush | Initiated Coverage | Outperform | $35.00 |
| Apr 24, 2026 | RBC Capital | Initiated Coverage | Outperform | $40.00 |
| Mar 25, 2026 | Evercore ISI Group | Initiated Coverage | Outperform | $46.00 |
| Feb 17, 2026 | Guggenheim | Maintained | Buy | $40.00 |
| Feb 17, 2026 | UBS | Initiated Coverage | Buy | $45.00 |
| Jan 7, 2026 | Leerink Partners | Initiated Coverage | Outperform | $46.00 |
| Dec 8, 2025 | Guggenheim | Maintained | Buy | $36.00 |
| Dec 1, 2025 | Guggenheim | Initiated Coverage | Buy | $32.00 |
| Oct 17, 2024 | Oppenheimer | Maintained | Outperform | $10.00 |
| Jun 10, 2024 | Oppenheimer | Maintained | Outperform | $9.00 |
| Sep 28, 2023 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| Aug 21, 2023 | HC Wainwright & Co. | Maintained | Buy | $2.00 |
| Aug 15, 2023 | SVB Leerink | Downgraded | Outperform → Market Perform | $2.00 |

## Frequently Asked Questions

### What is the latest analyst rating on DMRA?

On Sep 29, 2026, Wedbush maintained Damora Therapeutics at Outperform with a price target of $40.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).